Protection against SHIV-KB9 Infection by Combining rDNA and rFPV Vaccines Based on HIV Multiepitope and p24 Protein in Chinese Rhesus Macaques

Abstract EN

Developing an effective vaccine against HIV infection remains an urgent goal.

We used a DNA prime/fowlpox virus boost regimen to immunize Chinese rhesus macaques.

The animals were challenged intramuscularly with pathogenic molecularly cloned SHIV-KB9.

Immunogenicity and protective efficacy of vaccines were investigated by measuring IFN-γ levels, monitoring HIV-specific binding antibodies, examining viral load, and analyzing CD4/CD8 ratio.

Results show that, upon challenge, the vaccine group can induce a strong immune response in the body, represented by increased expression of IFN-γ, slow and steady elevated antibody production, reduced peak value of acute viral load, and increase in the average CD4/CD8 ratio.

The current research suggests that rapid reaction speed, appropriate response strength, and long-lasting immune response time may be key protection factors for AIDS vaccine.

The present study contributes significantly to AIDS vaccine and preclinical research.